Hua Lin

机构：Yunnan University, Kunming Medical University, Nanjing Traditional Chinese Medicine Hospital, Nanjing Drum Tower Hospital, Yunnan University of Traditional Chinese Medicine, Nanjing University · ORCID：0000-0001-5001-5567

发表论文 111 篇 · 总被引 5976 次 · h-index 29

代表论文

• Prevalence of Osteoporosis and Fracture in China (2021 · JAMA Network Open · 被引 570)
• FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice (2021 · Molecular Metabolism · 被引 28)
• A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas (2022 · Journal of Clinical Investigation · 被引 26)
• Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study (2022 · Archives of Osteoporosis · 被引 26)
• A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk (2022 · Acta Pharmacologica Sinica · 被引 24)
• Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis (2023 · Osteoporosis International · 被引 16)